Supplemental material
Emerging Microbes & Infections
Volume 8, 2019 - Issue 1
Original Articles
Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein
, , , 
, , , , , , , , , , & show all
Javier Gutiérrez-Álvarezd Department of Molecular and Cell Biology, National Center for Biotechnology-Spanish National Research Council (CNB-CSIC), Madrid, Spainhttps://orcid.org/0000-0003-0690-9496View further author information
https://orcid.org/0000-0003-0690-9496View further author information, , Nisreen M.A. Okbae Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlandshttps://orcid.org/0000-0002-2394-1079View further author information
https://orcid.org/0000-0002-2394-1079View further author information, V. Stalin Raje Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlandshttps://orcid.org/0000-0003-2250-8481View further author information
https://orcid.org/0000-0003-2250-8481View further author information, , , , , Bart L. Haagmanse Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlandshttps://orcid.org/0000-0001-6221-2015View further author information
https://orcid.org/0000-0001-6221-2015View further author information, , & show allRelated Research Data
Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein
Source:
Taylor & Francis
Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection
Source:
Elsevier BV
Pre-fusion structure of a human coronavirus spike protein
Source:
Springer Science and Business Media LLC
Acquisition of Complement Resistance through Incorporation of CD55/Decay-Accelerating Factor into Viral Particles Bearing Baculovirus GP64
Source:
American Society for Microbiology
Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction
Source:
Informa UK Limited
Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein
Source:
HAL CCSD
Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies
Source:
American Association for the Advancement of Science (AAAS)
Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.
Source:
American Association for the Advancement of Science (AAAS)
The global burden of premature mortality due to the Middle East respiratory syndrome (MERS) using standard expected years of life lost, 2012 to 2019.
Source:
Springer Science and Business Media LLC
A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein
Source:
American Society for Microbiology
Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein.
Source:
Nature Publishing Group
Beyond binding: antibody effector functions in infectious diseases.
Source:
Springer Science and Business Media LLC
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
Source:
Springer Science and Business Media LLC
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
Source:
Proceedings of the National Academy of Sciences
3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012.
Source:
Elsevier BV
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Source:
Springer Science and Business Media LLC
Linking provided by
